Using genetics of human fat cells to predict response to anti-diabetes drugs

January 10, 2019
In a new study published in Cell Stem Cell, a team of researchers from Perelman School of Medicine at the University of Pennsylvania, have demonstrated--using fat cells derived from human stem cells -- that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals. Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!

Why are you reading this article? (check all that apply)







How do you feel about science?







Send Feedback